Announcement • Aug 16
Aeternum Health Inc. announced delayed 10-Q filing On 08/14/2026, Aeternum Health Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. Announcement • Aug 13
Aeternum Health Inc. Announces Appointment of John M. Melkon to Board of Directors Aeternum Health Inc. announced that John M. Melkon joined the board of directors as a director and acted as a consultant to the Company. Mr. John Melkon is currently a senior advisor to the United States Military Academy at West Point. Previously, from 2012 to 2026 he was a Director and an Assistant Professor at the United States Military Academy and has been recently charged with building and leading the Critical Minerals Consortium. In this capacity he was responsible for facilitating the coordination, planning and execution of the strategic vision and mission to educate faculty, cadets and the community of practice. He also teaches Seminars on Sub-Saharan African Geography, as well as the Geography of the Middle East and North Africa. He serves as a Co-Chair for the Bilateral Defense Committee between the U.S. and South Africa. Prior to his service at CSCMO (Center for the Study of Civil/Military Operations), Mr. Melkon served as a Senior Operations Advisor to the United States Army Africa in Vicenza, Italy from 2009 to 2012. He was responsible for providing strategic liaison to Inter-Agency and multi-national partners and advising the command on critical operational planning. During that tenure he served the command in OPERATION ODYSSEY DAWN. He was also a Strategic Operations Officer for the Department of Defense from 2006 to 2009 with service to OPERATION ENDURING FREEDOM. Before re-entering public service Mr. Melkon worked as an International Banking Associate for Credit Suisse First Boston in Frankfurt, Germany. Prior to his civilian service with CSFB, Mr. Melkon was an Army Special Forces Officer and in over thirty years of national security service to the United States of America, Mr. Melkon has had operational and combat experience in Europe, Africa, the Middle East, and Central and South East Asia. His expertise spans a wide range of Civil-Military Operations, Unconventional Warfare, Counterterrorism, Counterinsurgency and Foreign Internal Defense. He is a graduate of the National Senior Intelligence Course and also an FBI Certified Crisis Negotiator. Mr. Melkon is currently a PhD Candidate at Stellenbosch University along with a Professor of Practice at North West University in South Africa. He received his A.B. in History from Princeton University, and he also holds an MBA from the Lowry Mays School of Business and an MPIA with honors from the George Bush School of Government and Public Service at Texas A&M University. He has been conferred an MA in European Politics and a Certificate of Professional Achievement in Enterprise Risk Management from Columbia University in 2022. He is also a Harvard John F Kennedy School Senior Executive in National and International Security. Announcement • Aug 05
Aeternum Health Inc. Announces Appointment of Paul E. Mann as President and Executive Chairman, Effective July 31, 2026 Aeternum Health Inc. announced that effective July 31, 2026, Paul E. Mann will become President and Executive Chairman of the Company. Mr. Mann has a 25-year career as an investor and entrepreneur. He is currently the Founder and Executive Chairman and Chief Executive Officer of ASP Isotopes Inc. and Chairman of Quantum Leap Energy, a wholly owned subsidiary of ASPI. Prior to becoming Executive Chairman of ASPI, he was the Chief Executive Officer of ASPI, during which time he built the company to a greater than $500 million market cap company which now employs over 400 people globally, has constructed three isotope enrichment facilities in Africa, a helium liquification facility and entered into multiple supply agreements with global companies for the supply of isotopes that will enable next generation semiconductors, healthcare and nuclear energy. He has spent more than 15 years as an investor working at institutions including Morgan Stanley, Soros Fund Management and Highbridge Capital Management. He is a U.K. citizen and graduated from Cambridge University with an MA and an MEng in Chemical Engineering, and he is a CFA Charterholder. 
